U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07747493) titled '68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy' on July 21.
Brief Summary: Focal therapy is a minimally invasive treatment option for some men with localized prostate cancer. Unlike surgery or radiation, focal therapy treats only the area of the prostate containing clinically significant cancer, with the goal of preserving urinary and sexual function. Successful focal therapy depends on accurately identifying all areas of clinically significant prostate cancer before treatment. Currently, multiparametric magnetic resonance imaging (MRI) is the standard imaging method used to determine whether a patient ...